215 related articles for article (PubMed ID: 3973464)
21. Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosis.
Herzig KH; Domagk J; Nustede R; Stern M; Bewig B; Cichy WK; Fölsch UR
Scand J Gastroenterol; 1997 Apr; 32(4):315-9. PubMed ID: 9140152
[TBL] [Abstract][Full Text] [Related]
22. [The carcinoembryonic antigen in chronic pancreatitis].
Brailski Kh; Mendizova A; Milkov V
Vutr Boles; 1990; 29(2):26-30. PubMed ID: 2238619
[TBL] [Abstract][Full Text] [Related]
23. Thr28, Nle31 CCK-9--an useful CCK analogue in stimulation tests of pancreatic exocrine function.
Schusdziarra V; Classen M
Z Gastroenterol; 1988 Dec; 26(12):762-6. PubMed ID: 3245254
[TBL] [Abstract][Full Text] [Related]
24. TRH-immunoreactivity in chronic pancreatitis.
Duntas L; Glasbrenner B; Wolf C; Pieramico O; Büchler M; Malfertheiner P
Hepatogastroenterology; 1992 Oct; 39(5):413-6. PubMed ID: 1459520
[TBL] [Abstract][Full Text] [Related]
25. Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure.
Regan PT; DiMagno EP
Gastroenterology; 1980 Mar; 78(3):484-7. PubMed ID: 7351287
[TBL] [Abstract][Full Text] [Related]
26. [Stimulation of immunoglobulin E formation in chronic pancreatitis by alcohol drinking and exocrine pancreatic insufficiency].
Raithel M; Dormann H; Farnbacher M; Weidenhiller M; Hahn EG; Schneider HT
Z Gastroenterol; 2001 Apr; 39(4):269-76. PubMed ID: 11367975
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin octapeptide (CCK-8) concentration in plasma is not affected in functional abdominal pain in children.
Uścinowicz M; Kaczmarski M
Rocz Akad Med Bialymst; 2005; 50():257-60. PubMed ID: 16358979
[TBL] [Abstract][Full Text] [Related]
28. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
29. [Enzyme substitution in the treatment of pain in chronic pancreatitis. Significance of feedback regulation in pancreatic secretion].
Adler G
Dtsch Med Wochenschr; 1988 Jul; 113(26):1075-9. PubMed ID: 3289883
[No Abstract] [Full Text] [Related]
30. Fasting serum cholecystokinin immunoreactivity in chronic relapsing pancreatitis.
Ederle A; Vantini I; Harvey RF; Cavallini G; Piubello W; Benini L; Scuro LA
Ric Clin Lab; 1978; 8(3):199-206. PubMed ID: 746300
[TBL] [Abstract][Full Text] [Related]
31. Plasma cholecystokinin levels in patients with chronic pancreatitis.
Schafmayer A; Becker HD; Werner M; Fölsch UR; Creutzfeldt W
Digestion; 1985; 32(2):136-9. PubMed ID: 4043564
[TBL] [Abstract][Full Text] [Related]
32. Serum immunoreactive trypsin after secretin stimulation in chronic pancreatitis.
Vezzadini P; Gullo L; Sternini C; Bonora G; Ferri GL; Labò G
Scand J Gastroenterol Suppl; 1980; 62():29-34. PubMed ID: 6935752
[TBL] [Abstract][Full Text] [Related]
33. Diurnal profile of pancreatic exocrine secretion and plasma levels of gut hormones (cholecystokinin and pancreatic polypeptide).
Nakano I; Funakoshi A; Shinozaki H; Miyazaki K; Tateishi K; Hamaoka T
Gastroenterol Jpn; 1987 Dec; 22(6):748-55. PubMed ID: 3443256
[TBL] [Abstract][Full Text] [Related]
34. Zinc status in chronic pancreatitis and its relationship with exocrine and endocrine insufficiency.
Girish BN; Rajesh G; Vaidyanathan K; Balakrishnan V
JOP; 2009 Nov; 10(6):651-6. PubMed ID: 19890187
[TBL] [Abstract][Full Text] [Related]
35. Parotid salivary gland function in patients with exocrine pancreatic insufficiency.
McColl KE; Brodie MJ; Whitesmith R; Gray KF; Thomson TJ
Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):407-12. PubMed ID: 525218
[TBL] [Abstract][Full Text] [Related]
36. Gallbladder motility and cholecystokinin secretion in chronic pancreatitis: relationship with exocrine pancreatic function.
Gielkens HA; Eddes EH; Vecht J; van Oostayen JA; Lamers CB; Masclee AA
J Hepatol; 1997 Aug; 27(2):306-12. PubMed ID: 9288605
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
Eddes EH; Masclee AA; Gielkens HA; Verkijk M; Vecht J; Biemond I; Lamers CB
Pancreas; 1999 Aug; 19(2):119-25. PubMed ID: 10438157
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological role of cholecystokinin in humans.
Otsuki M
J Gastroenterol Hepatol; 2000 Mar; 15 Suppl():D71-83. PubMed ID: 10759224
[TBL] [Abstract][Full Text] [Related]
39. Release of radioimmunologic cholecystokinin in human subjects.
Becker HD; Werner M; Schafmayer A
Am J Surg; 1984 Jan; 147(1):124-9. PubMed ID: 6691538
[TBL] [Abstract][Full Text] [Related]
40. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
